Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)-Reference-Cited by-同舟云学术

Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)

Published:2023-09 Issue: Volume:229 Page:107-113
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Grobost Vincent,Hammi Sami,Pereira Bruno,Guilhem Alexandre,Duffau Pierre,Seguier Julie,Parrot Antoine,Gautier Giovanni,Alric Laurent,Kerjouan Mallorie,Le Guillou Xavier,Simon Delphine,Chaussavoine Laurent,Rondeau-Lutz Murielle,Leguy-Seguin Vanessa,Delagrange Laura,Lavigne Christian,Maillard Hélène,Dupuis-Girod Sophie

Publisher

Elsevier BV

Subject

Hematology

Reference35 articles.

1. The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia;Grosse;Genet. Med.,2014

2. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study;Donaldson;Thorax,2014

3. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence;Bideau;Popul.,1989

4. Hereditary hemorrhagic telangiectasia;Guttmacher;N. Engl. J. Med.,1995

5. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care;Al-Samkari;Blood.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review;Journal of Clinical Medicine;2024-09-12

2. How I treat bleeding in hereditary hemorrhagic telangiectasia;Blood;2024-08-29

3. Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia;Journal of Clinical Medicine;2023-12-15